Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

RTX entered the second half of 2026 with strong operating momentum: second-quarter organic sales increased 16%, adjusted EPS increased 21%, every operating segment expanded adjusted margin, backlog reached $289 billion, and management raised its full-year sales, EPS and free-cash-flow outlook. Additional support comes from more than 800 GTF orders and commitments during 2026 through July and a seven-year, $22.9 billion Tomahawk award announced in August. The balanced rating reflects substantial execution requirements: RTX must convert its backlog while expanding capacity, manage Pratt & Whitney fleet and supply-chain issues, control long-duration defense-program costs and sustain commercial-aerospace demand.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets22 analysts · as of 18 Aug 2026
Low · most bearish analyst$183.98
Mean target$232.27
High · most bullish analyst$265.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$183.9820%

Supply-chain constraints, unfavorable contract execution, customer-production disruptions or additional Pratt & Whitney fleet costs slow backlog conversion and force management to reduce its raised sales, EPS or free-cash-flow outlook. Lower productivity or weaker commercial demand would compound the pressure despite the large backlog.

Base CaseCentral scenario
$232.2755%
Matches the consensus mean

RTX delivers near its raised 2026 outlook, with backlog conversion and commercial aftermarket demand offsetting normal capacity-ramp friction, program-mix variability and continuing Pratt & Whitney execution costs.

Bull CaseUpside scenario
$265.0025%

Capacity additions and digital productivity enable faster backlog conversion without sacrificing margins; commercial aftermarket growth remains strong; GTF Advantage execution and the more-than-8,000-engine order backlog reinforce Pratt & Whitney's installed-base economics; and the Tomahawk and other multiyear munitions programs support durable defense growth. This outcome assumes results remain above the raised 2026 outlook and major program or supply-chain charges are contained.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • A $289 billion backlog, up 22% year over year, provides substantial demand visibility across commercial aerospace and defense.
  • Second-quarter 2026 organic sales increased 16%, adjusted EPS increased 21%, and adjusted margins improved across Collins Aerospace, Pratt & Whitney and Raytheon.
  • Long-duration demand is reinforced by more than 8,000 GTF engines in backlog and the seven-year, $22.9 billion Tomahawk production contract.
Sign in / Sign up to read more
Key Investment Risks
  • Backlog conversion requires successful execution of a broad capacity expansion, including RTX's stated $3.1 billion of 2026 capital-expansion investment.
  • Pratt & Whitney remains exposed to fleet-management, product-quality, supply-chain and customer-compensation risks, including the previously disclosed powder-metal matter.
  • Defense results remain sensitive to government spending priorities, contract cost control, regulatory approvals and the timing of international awards.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.